Center for Scientific Review; Notice of Closed Meetings, 75009-75010 [2023-24116]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 210 / Wednesday, November 1, 2023 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Amended Notice
of Meeting
Notice is hereby given of a change in
the meeting of the National Institute of
Neurological Disorders and Stroke
Special Emphasis Panel, October 31,
2023, 11:00 a.m. to November 03, 2023,
05:00 p.m., National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 which
was published in the Federal Register
on September 25, 2023, FR Doc 2023–
21368, 88 FR 67334.
This notice is being amended to
change the dates and time of this twoday meeting to November 3, 2023, and
November 17, 2023; The start time has
changed to 10:00 a.m., and the end time
remains the same. The meeting is closed
to the public.
Dated: October 26, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2023–24115 Filed 10–31–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
ddrumheller on DSK120RN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Glioma, Multiple Sclerosis, and
Neuroinflammation.
Date: November 29, 2023.
Time: 1:30 p.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
VerDate Sep<11>2014
19:48 Oct 31, 2023
Jkt 262001
Contact Person: Salma Asmat Quraishi,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–0592, salma.quraishi@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: HIV associated
immunopathogenesis, vaccines, co-infections
and cancer.
Date: December 6, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kenneth A. Roebuck,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5214,
MSC 7852, Bethesda, MD 20892, (301) 435–
1166, roebuckk@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Learning, Memory, Language,
Communication.
Date: December 7, 2023.
Time: 11:30 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sepandarmaz Aschrafi,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040D,
Bethesda, MD 20892, (301) 451.4251,
Armaz.aschrafi@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
75009
Individuals who need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting.
Name of Committee: AIDS Research
Advisory Committee, NIAID.
Date: January 30, 2024.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: Report of Division Director and
Division Staff.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 8D49,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Pamela Gilden, Branch
Chief, Science Planning and Operations
Branch, Division of AIDS, National Institute
of Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room
8D49, Rockville, MD 20852–9831, 301–594–
9954, pamela.gilden@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice at least 10 days in advance of the
meeting. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.niaid.nih.gov/about/committees-aidsresearch, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 26, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
Dated: October 27, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–24113 Filed 10–31–23; 8:45 am]
[FR Doc. 2023–24110 Filed 10–31–23; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the AIDS Research Advisory
Committee, NIAID.
The meeting will be open to the
public. The open session will be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov).
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
E:\FR\FM\01NON1.SGM
01NON1
75010
Federal Register / Vol. 88, No. 210 / Wednesday, November 1, 2023 / Notices
ddrumheller on DSK120RN23PROD with NOTICES1
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Drug
Discovery and Molecular Pharmacology.
Date: November 15, 2023.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jeffrey Smiley, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6194,
MSC 7804, Bethesda, MD 20892, (301) 272–
4596, smileyja@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Auditory, Visual and Cognitive
Neuroscience.
Date: November 30, 2023.
Time: 11:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Alena Valeryevna
Savonenko, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 1009J, Bethesda, MD 20892 (301) 594–
3444, savonenkoa2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; AREA/
REAP: Respiratory, Cardiac and Circulatory
Sciences.
Date: November 30, 2023.
Time: 1:00 p.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kirk E Dineley, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room 806E,
Bethesda, MD 20892, (301) 867–5309,
dineleyke@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Skeletal Muscle and Exercise
Physiology/Musculoskeletal Rehabilitation
Sciences.
Date: December 5, 2023.
Time: 9:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aftab A Ansari, Ph.D.,
Scientific Review, Officer Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4108,
MSC 7814, Bethesda, MD 20892, (301) 237–
9931, ansaria@csr.nih.gov.
VerDate Sep<11>2014
19:48 Oct 31, 2023
Jkt 262001
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Musculoskeletal, Dental and Oral
Sciences.
Date: December 6, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Chee Lim, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4128, Bethesda, MD 20892,
(301) 435–1850, limc4@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–21–
120: Fogarty Global Infectious Disease
Research Training Program.
Date: December 8, 2023.
Time: 10:00 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dayadevi Jirage, Ph.D.,
Scientific Review, Officer Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4422,
Bethesda, MD 20892, (301) 867–5309,
jiragedb@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 26, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2023–24116 Filed 10–31–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Fiscal Year (FY) 2024 Notice of
Supplemental Funding Opportunity
Substance Abuse and Mental
Health Services Administration,
Department of Health and Human
Services (HHS).
ACTION: Notice of intent to award
supplemental funding.
AGENCY:
This notice is to inform the
public that the Substance Abuse and
Mental Health Services Administration
(SAMHSA) is supporting a supplement
in scope of the original award to the
Community-Based, Advocacy-Focused,
Data-Driven, Coalition-Building
Association (CADCA) recipient funded
in FY 2019 under the National Anti-
SUMMARY:
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Drug Coalitions Training and Workforce
Development Grant Program (Short
Title: Coalitions Training Grant), Notice
of Funding Opportunity (NOFO) SP–19–
002. The recipient may receive up to
$562,500. The supplemental funding
will extend the project period by 10months until September 29, 2024 and
will: leverage existing resources and
conference support to expand
SAMHSA’s scope and capacity; and
provide training and technical
assistance to state and community
prevention leaders, including members
of anti-drug community coalitions from
around the country who are committed
to addressing the evolving needs of the
behavioral health field. The training and
workforce development activities
supported through this grant include
SAMHSA’s Prevention Day and
SAMHSA’s participation in the annual
National Leadership Forum and annual
Mid-Year Training Institute of CADCA.
FOR FURTHER INFORMATION CONTACT:
David Lamont Wilson, Public Health
Analyst, Substance Abuse and Mental
Health Services Administration, 5600
Fishers Lane, Rockville, MD 20857,
telephone 240–276–2588; email:
david.wilson@samhsa.hhs.gov.
SUPPLEMENTARY INFORMATION:
Funding Opportunity Title: FY 2019
National Anti-Drug Coalitions Training
and Workforce Development Grant
Program (Short Title: Coalitions
Training Grant), Notice of Funding
Opportunity SP–19–002.
Assistance Listing Number: 93.243.
Authority: The Coalitions Training
Grant is authorized under sections 509,
516 and 520A of the Public Health
Service Act, as amended.
Justification: Eligibility for this
supplemental funding is limited to
CADCA, which was funded in FY 2019
under the National Anti-Drug Coalitions
Training and Workforce Development
Grant Program (Short Title: Coalitions
Training Grant). CADCA is the only
national organization that provides
training and technical assistance
annually through a national leadership
conference for thousands of members of
community coalitions dedicated to
preventing substance use. CADCA is
currently the sole organization that
plays a major role in helping to
strengthen and develop the nation’s
prevention infrastructure of anti-drug
coalitions in support of ongoing
activities funded by SAMHSA’s priority
prevention grant programs. It is the only
identified organization that currently
meets this experience level and national
reach to over 5,000 identified anti-drug
coalitions across the country.
E:\FR\FM\01NON1.SGM
01NON1
]]>Agencies
[Federal Register Volume 88, Number 210 (Wednesday, November 1, 2023)]
[Notices]
[Pages 75009-75010]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-24116]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant
[[Page 75010]]
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Drug Discovery and Molecular Pharmacology.
Date: November 15, 2023.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jeffrey Smiley, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6194, MSC 7804, Bethesda, MD
20892, (301) 272-4596, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflicts: Auditory, Visual and Cognitive
Neuroscience.
Date: November 30, 2023.
Time: 11:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Alena Valeryevna Savonenko, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1009J, Bethesda, MD 20892 (301)
594-3444, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; AREA/REAP: Respiratory, Cardiac and Circulatory Sciences.
Date: November 30, 2023.
Time: 1:00 p.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kirk E Dineley, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institute of Health,
6701 Rockledge Drive, Room 806E, Bethesda, MD 20892, (301) 867-5309,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Skeletal Muscle and Exercise Physiology/
Musculoskeletal Rehabilitation Sciences.
Date: December 5, 2023.
Time: 9:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aftab A Ansari, Ph.D., Scientific Review,
Officer Center for Scientific Review, National Institutes of Health,
6701 Rockledge Drive, Room 4108, MSC 7814, Bethesda, MD 20892, (301)
237-9931, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Musculoskeletal, Dental and Oral Sciences.
Date: December 6, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Chee Lim, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4128, Bethesda, MD 20892, (301) 435-1850,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-21-120: Fogarty Global Infectious Disease Research
Training Program.
Date: December 8, 2023.
Time: 10:00 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dayadevi Jirage, Ph.D., Scientific Review,
Officer Center for Scientific Review, National Institutes of Health,
6701 Rockledge Drive, Room 4422, Bethesda, MD 20892, (301) 867-5309,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: October 26, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2023-24116 Filed 10-31-23; 8:45 am]
BILLING CODE 4140-01-P
